Omron Corp. (OTCMKTS:OMRNY) Sees Significant Growth in Short Interest
by Renee Jackson · The Cerbat GemOmron Corp. (OTCMKTS:OMRNY – Get Free Report) was the recipient of a significant increase in short interest in December. As of December 15th, there was short interest totaling 14,864 shares, an increase of 65.4% from the November 30th total of 8,986 shares. Based on an average daily trading volume, of 76,052 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 76,052 shares, the days-to-cover ratio is currently 0.2 days.
Omron Stock Performance
Omron stock traded down $0.11 during midday trading on Friday, reaching $25.18. 17,887 shares of the company traded hands, compared to its average volume of 33,603. Omron has a 12 month low of $23.23 and a 12 month high of $35.25. The business has a 50 day moving average of $26.24 and a two-hundred day moving average of $26.52. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.14 and a quick ratio of 1.40. The firm has a market capitalization of $5.19 billion, a price-to-earnings ratio of 25.95, a price-to-earnings-growth ratio of 0.40 and a beta of 0.97.
Omron (OTCMKTS:OMRNY – Get Free Report) last announced its earnings results on Friday, November 7th. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.19). Omron had a return on equity of 3.01% and a net margin of 3.47%.The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.34 billion. As a group, research analysts predict that Omron will post 0.42 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Separately, Zacks Research lowered Omron from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.
Get Our Latest Research Report on Omron
Hedge Funds Weigh In On Omron
A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its stake in shares of Omron Corp. (OTCMKTS:OMRNY – Free Report) by 180.8% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,488 shares of the company’s stock after purchasing an additional 958 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $40,000 at the end of the most recent quarter. Institutional investors and hedge funds own 1.09% of the company’s stock.
About Omron
Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.